U.S. markets closed

Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ)

Shenzhen - Shenzhen Delayed Price. Currency in CNY
Add to watchlist
91.53-1.03 (-1.11%)
As of 10:27AM CST. Market open.

Shenyang Xingqi Pharmaceutical Co.,Ltd

No. 68, Lishui Street
Dongling District
86 24 8802 6022

IndustryMedical Instruments & Supplies
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Ms. E. GaoGM & DirectorN/AN/A1972
Ms. Yanan ChengCFO & DirectorN/AN/A1974
Mr. Gang PengDeputy Gen. Mang.N/AN/A1958
Mr. Shao Yao ZhangDeputy GM, Sec. of the Board of Directors & Non-Independent DirectorN/AN/A1970
Mr. Zhi Qiang WangHead of Audit Department and Employee Representative of the Supervisory BoardN/AN/A1976
Mr. Qiang YangDeputy GM & DirectorN/AN/A1984
Mr. Kun ZhangChairman of the Supervisory Board and Production Mang.N/AN/A1976
Suo WangSecurities RepresentativeN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.


Shenyang Xingqi Pharmaceutical Co., Ltd engages in the research and development, production, and sale of ophthalmic products in China. It offers corneal, anti-bacteria, artificial tears, anti-inflammation, surgical perfusate, mydriactics, anti-fatigue, and pre dry and over dry eye treatment products. The company is based in Shenyang, China.

Corporate Governance

Shenyang Xingqi Pharmaceutical Co.,Ltd’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.